Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Pigmentation

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of a canine melanoma vaccine in the management of malignant melanoma in an African penguin (Spheniscus demersus).

Journal of the American Veterinary Medical Association·2021

Same author

Evaluation of tyrosinase expression in canine and equine melanocytic tumors.

American journal of veterinary research·2012

Same author

A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26.

Genomics·2010

Same author

Diffuse intestinal T-cell lymphosarcoma in a yellow-naped Amazon parrot (Amazona ochrocephala auropalliata).

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2008

Same author

Heritability and segregation analysis of osteosarcoma in the Scottish deerhound.

Genomics·2007

Same author

Four novel mutations in the PITX2 gene in patients with Axenfeld-Rieger syndrome.

Ophthalmic research·2002

Search research articles

Related Experiment Video

Updated: May 5, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Equine melanocytic tumors.

Jeffrey C Phillips¹, Luis M Lembcke

¹College of Veterinary Medicine, Lincoln Memorial University, 6965 Cumberland Gap Parkway, Harrogate, TN 37752, USA.

The Veterinary Clinics of North America. Equine Practice

|November 26, 2013

Summary

Equine melanomas, common in gray horses, can become malignant. Understanding their genetic factors is key to developing targeted therapies for treatment and prevention.

Area of Science:

Veterinary Dermatology
Equine Oncology
Molecular Genetics

Background:

Melanomas are prevalent skin tumors in horses, particularly affecting adult gray horses, with up to 80% prevalence.
While initially benign, a significant proportion (up to two-thirds) of equine melanomas can progress to malignant forms if untreated.
Current treatments focus on solitary lesions and do not prevent recurrence or malignant transformation.

Purpose of the Study:

To investigate the molecular genetic factors driving equine melanoma formation.
To identify potential targets for novel therapeutic strategies.
To explore avenues for disease prevention in horses.

Main Methods:

Analysis of molecular and genetic profiles of equine melanoma tumors.

Keywords:

Chemotherapy Genetics Horse Immunotherapy Melanoma Treatment Vaccine

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Related Experiment Videos

Last Updated: May 5, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Comparative studies of benign and malignant melanocytic lesions.

Identification of key genetic mutations and pathways involved in tumor development.

Main Results:

Specific molecular genetic factors have been identified as crucial in the development of equine melanomas.
These factors are associated with both tumor initiation and progression towards malignancy.
The findings highlight distinct genetic pathways implicated in equine skin tumor formation.

Conclusions:

Understanding the molecular genetics of equine melanomas is essential for advancing treatment.
Targeted therapies based on identified genetic factors offer promise for treating and preventing these tumors.
Further research into these genetic drivers could revolutionize equine melanoma management.